BioSpace News Archive

Biocom California, the association representing the life science industry of California, issued the following statement regarding the collapse of Silicon Valley Bank.

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee will convene April 17, 2023 to review data supporting the new drug application (NDA) for sulbactam-durlobactam (SUL-DUR).

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced The Lancet published detailed results from the pivotal Phase 3 SKYLIGHT 1™ study of fezolinetant, an investigational oral, nonhormonal compound being studied for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause.

Acasti Pharma Inc. a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, announced that it has applied and received approval for a voluntary delisting of its common shares from the TSX Venture Exchange.

Combined Therapeutics Inc. today announced its intellectual property position reinforcement in mRNA vaccine technology with the issue of U.S. Patent 11,596,685 by the United States Patent and Trademark Office (USPTO) on March 7, 2023.

Zynex, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022.

Ratio Therapeutics Inc. today announced the appointment of Dr. Noel Monks as the company’s Head of Biology.

Premier Research and InSilicoTrials have partnered to create safer, faster, and more efficient pathways to regulatory approval for rare disease treatments.

AnHeart Therapeutics today announced acceptance of an oral presentation at the European Lung Cancer Congress (ELCC) 2023, held in Copenhagen, Denmark and virtually, March 29 - April 1.

AbbVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one late-breaking presentation during the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21, in New Orleans, Louisiana.